CAS: 54613-99-9; Boc-Lys(2-Cl-Z)-Oh

该化合物是一种合成氨基酸衍生物,其特点是用各种功能组来改造赖氨基脊柱,其特点是存在一种氯苯基杂质,这助长了其疏水性,以及甲基氧基和碳基组群,从而增强了其在有机溶剂中的再活性和溶性.二甲基乙基碳基组提供了障碍,能够影响其生物活动以及与其他分子的相互作用.通常情况下,这些修改是为了提高化合物的稳定性,生物利用率或生物化学应用的特性.该化合物可用于制药研究,特别是开发基于浸泡的药物或作为有机合成的构件.其独特结构表明它可能与生物目标发生相互作用,从而引起对医药化学的兴趣.然而,为了充分阐明其特性和潜在应用,有必要进行详细研究.

结构式图片

相似化合物

133970-31-7 2389-45-9 55878-47-2

上下游产品

CAS号56-87-1 L-赖氨酸 | CAS号13734-28-6 B°C-L-赖氨酸 | CAS号66438-39-9 Nα-B°C-Nepsilon...

合成工艺路线路线简述

  • 合成目标产物 N-Boc-N'-(2-Chlorobenzyloxycarbonyl)-L-Lysine 主要起始原料 2-Chlorobenzyl Alcohol
  • (文献来源)合成步骤主要原料 2-Chlorobenzyl Alcohol
邻氯苄醇置于sodium Hydroxide体系中,用 1,4-二氧六环,苯 作为反应溶剂,化学反应 60.0H,反应生成 N-叔丁氧羰基-N'-(2-氯苄氧羰基)-L-赖氨酸
参考文献:Salem,Ezzeldin M.; Schou,O.,Indian Journal Of Chemistry-Section B Organic And Medicinal Chemistry,1980,Vol. 19,# 1,P. 62-64
标题:Salem,Ezzeldin M.; Schou,O.,Indian Journal Of Chemistry-Section B Organic And Medicinal Chemistry,1980,Vol. 19,# 1,P. 62-64

海关参考信息

专利信息


专利号:US-2007179279-A1
优先权日:2005-12-30
标题:Methods for the synthesis of arginine-containing peptides
发明人:CHEN LIN; ROBERTS CHRISTOPHER R
权利人:CHEN LIN; ROBERTS CHRISTOPHER R
摘要:Methods for the synthesis of arginine-containing peptides are provided. The methods include a step that minimizes contact of side chain protected arginine with base prior to the coupling step.

专利号:US-2004110228-A1
优先权日:2002-04-01
标 题:Combinatorial organic synthesis of unique biologically active compounds
发明人:MCALPINE SHELLI R; TAYLOR RACHEL E; BOLLA MEGAN L; SEGALL ANCA M
摘要:The invention provides a method for making a combinatorial library of cyclic compounds, such as Holliday junction-trapping compounds, comprising the steps of (a) obtaining a plurality of trimers according to the generic structure X 1- X 2- X 3 , wherein X 1 , X 2 and X 3 can be independently any naturally or nonnaturally occurring amino acids or peptidomimetics thereof; (b) optionally coupling a spacer S to the trimer at either end; (c) cyclizing two trimers or trimer-spacer conjugates in a head-to-tail orientation; thereby obtaining a combinatorial library of compounds, wherein the library does not include an unmodifed or naturally occurring Holliday Junction-trapping compounds. The invention additionally provides methods macrocyclic compounds that are synergimycin derivatives.

专利号:US-10112976-B2
优先权日:2014-06-30
标 题:Process for the production of D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide
发明人:ZHAO XINJUN; ZHENG MINYU; YU XIAOZHONG; GAO HANRONG; CORNILLE FABRICE
权利人:FLAMMA SPA
摘要:The invention relates to a process for solution-phase synthesis of D-Arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-L-phenylalaninamide, an active ingredient used for both common and rare diseases including a mitochondrial targeted therapy for ischemia reperfusion injury.

专利号:US-4011182-A
优先权日:1975-03-21
标 题:Cyclic undecapeptide analogs of somatostatin and intermediates
发明人:SARANTAKIS DIMITRIOS
权利人:AMERICAN HOME PROD
摘要:Cyclic undecapeptide analogs of somatostatin without cysteine amino acid residues and intermediates obtained in the synthesis of such compounds are described. These cyclic undecapeptides inhibit the secretion of the hormone somatotropin (growth hormone) without materially affecting glucagon levels.

专利号:US-5175146-A
优先权日:1989-12-05
标题 :Synthetic calcitonin peptides
发明人:BASAVA CHANNA; HOSTETLER KARL Y
权利人:VICAL INC
摘要:Synthetic hypocalcemic peptides which are similar in biological properties to native calcitonins as clinically useful agents. The peptides comprise analogues of native calcitonins having amino acid substitutions and deletions which act to improve potency, prolong duration of the hormonal effect, enhance receptor binding, and increase oral or nasal bioavailability. The calcitonin peptide analogues are less expensive and more easily synthesized than native calcitonins, and have improved resistance to inactivation or degradation. Methods are provided for the synthesis of these peptides. Also, disclosed are novel cyclic peptides, including calcitonin, having increased stability with respect to proteolysis. Methods for the synthesis of these peptides are provided, comprising converting disulfide cyclic peptides and proteins to enzymatically and chemically stable cyclic peptide structures by the replacement of cysteine residues with dicarboxylic acids and diamino acids. The method is applicable to various naturally occurring peptides, their synthetic analogues or derivatives, and proteins.

专利号:US-7662914-B2
优先权日:2001-06-05
标 题 :Native chemical ligation with three or more components
发明人:VILLAIN MATTEO; GAERTNER HUBERT
权利人:AMYLIN PHARMACEUTICALS INC
摘要:The invention provides a method of assembling oligopeptide intermediates in a native chemical ligation reaction that eliminates self-ligation of bi-functional intermediates. An important aspect of the invention is a bi-functional intermediate with an N-terminal cyclic thiazolidine protecting group which effectively prevents self-ligation in the chemical assembly process. The present invention is useful in methods for convergent synthesis of polypeptides and proteins and improves the efficiency of native chemical ligation reactions, particularly where three or more peptide fragments are used to assemble a polypeptide or protein product.
上海吉尔多肽有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.glbiochem.com
电话: 86-21-61263309👤
📞上海吉尔多肽有限公司 ⚠️参考联系方式

销售电话:86-21-61263309
邮箱:ymbetter@glbiochem.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
上海正极生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.bioplus.com.cn
电话: 021-64847500👤
📞上海正极生物科技有限公司 ⚠️参考联系方式

销售电话:021-64847500
邮箱:sales@bioplus.com.cn
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
成都悦康科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.yuekangtech.com
电话: 0086 (28) 8669-1469👤
📞成都悦康科技有限公司 ⚠️参考联系方式

销售电话:0086 (28) 8669-1469
邮箱:richard@yuekangtech.com
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

主要参考文献

[参考文献]: Luckose F, Et Al. Effects Of Amino Acid Derivatives On Physical, Mental, And Physiological Activities. Crit Rev Food Sci Nutr. 2015;55(13):1793-1144.

合成参考文献


参考文献:10.1007/978-1-0716-0227-0_3
摘要:Adhikary R, Dawson PE. In Situ Neutralization Protocols for Boc-SPPS. Methods Mol Biol. 2020;2103():29–40. doi: 10.1007/978-1-0716-0227-0_3.
参考文献:10.1007/978-1-4939-1486-9_5
摘要:Buer BC, Marsh EN. Design, synthesis, and study of fluorinated proteins. Methods Mol Biol. 2014;1216():89–116. doi: 10.1007/978-1-4939-1486-9_5.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知